Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis

S Bloom, S Kiilerich, M R Lassen, A Forbes, K Leiper, E Langholz, E J Irvine, C O'Morain, D Lowson, S Orm

60 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis'. Together they form a unique fingerprint.

Medicine & Life Sciences